참고문헌
- Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749. https://doi.org/10.1210/jc.2003-032046
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
- Robin G, Gallo C, Catteau-Jonard S, et al. Polycystic ovary-like abnormalities (PCO-L) in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 2012;97:4236-4243. https://doi.org/10.1210/jc.2012-1836
- Keevil BG. How do we measure hyperandrogenemia in patients with PCOS? J Clin Endocrinol Metab 2014;99:777-779. https://doi.org/10.1210/jc.2014-1307
- Weenen C, Laven JS, Von Bergh AR, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77-83. https://doi.org/10.1093/molehr/gah015
- Pigny P, Merlen E, Robert Y, et al. Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003;88:5957-5962. https://doi.org/10.1210/jc.2003-030727
- Sahmay S, Atakul N, Oncul M, Tuten A, Aydogan B, Seyisoglu H. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013;170:157-161. https://doi.org/10.1016/j.ejogrb.2013.05.019
- Rosenfield RL, Wroblewski K, Padmanabhan V, Littlejohn E, Mortensen M, Ehrmann DA. Antimullerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril 2012;98:242-249. https://doi.org/10.1016/j.fertnstert.2012.03.059
- Sahmay S, Aydin Y, Oncul M, Senturk LM. Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms. J Assist Reprod Genet 2014;31:213-220. https://doi.org/10.1007/s10815-013-0149-0
- Pinola P, Morin-Papunen LC, Bloigu A, et al. Anti-Mullerian hormone: correlation with testosterone and oligo-or amenorrhoea in female adolescence in a population-based cohort study. Hum Reprod 2014;29:2317-2325. https://doi.org/10.1093/humrep/deu182
- Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab 2013;98:3332-3340. https://doi.org/10.1210/jc.2013-1393
- Dewailly D, Gronier H, Poncelet E, et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 2011;26:3123-3129. https://doi.org/10.1093/humrep/der297
- Li Y, Ma Y, Chen X, et al. Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism. J Assist Reprod Genet 2012;29:1147-1151. https://doi.org/10.1007/s10815-012-9839-2
- Cui Y, Shi Y, Cui L, Han T, Gao X, Chen ZJ. Age-specific serum antimullerian hormone levels in women with and without polycystic ovary syndrome. Fertil Steril 2014;102:230-236. https://doi.org/10.1016/j.fertnstert.2014.03.032
- Lauritsen MP, Bentzen JG, Pinborg A, et al. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod 2014;29:791-801. https://doi.org/10.1093/humrep/det469
- Escobar-Morreale HF, Carmina E, Dewailly D, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 2012;18:146-170. https://doi.org/10.1093/humupd/dmr042
- Sung YA. Hyperandrogenism in women: polycystic ovary syndrome. Hanyang Med Rev 2012;32:197-202. https://doi.org/10.7599/hmr.2012.32.4.197
- Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003;9:505-514. https://doi.org/10.1093/humupd/dmg044
- Homburg R, Ray A, Bhide P, et al. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study. Hum Reprod 2013;28:1077-1083. https://doi.org/10.1093/humrep/det015
- Koninger A, Koch L, Edimiris P, et al. Anti-Mullerian hormone: an indicator for the severity of polycystic ovarian syndrome. Arch Gynecol Obstet 2014;290:1023-1030. https://doi.org/10.1007/s00404-014-3317-2
- Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004;89:318-323. https://doi.org/10.1210/jc.2003-030932
- Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 2005;20:1820-1826. https://doi.org/10.1093/humrep/deh850
- Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:941-945. https://doi.org/10.1210/jc.2005-2076
- Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod 2009;24:2917-2923. https://doi.org/10.1093/humrep/dep225
- Eldar-Geva T, Margalioth EJ, Gal M, et al. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod 2005;20:1814-1819. https://doi.org/10.1093/humrep/deh873
- Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 2004;10:107-117. https://doi.org/10.1093/humupd/dmh010
- Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 2002;124:601-609. https://doi.org/10.1530/rep.0.1240601
- Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, Ho HN. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod 2008;23:952-957. https://doi.org/10.1093/humrep/den015
- Wang JG, Nakhuda GS, Guarnaccia MM, Sauer MV, Lobo RA. Mullerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome. Am J Obstet Gynecol 2007;196:77.
- Hwang YI, Sung NY, Koo HS, et al. Can high serum anti-Mullerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients? Clin Exp Reprod Med 2013;40:135-140. https://doi.org/10.5653/cerm.2013.40.3.135
- Li L, Chen X, Mo Y, Chen Y, Wenig M, Yang D. Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome. Wien Klin Wochenschr 2010;122:519-524. https://doi.org/10.1007/s00508-010-1426-x
- Tremellen K, Zander-Fox D. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan. Aust N Z J Obstet Gynaecol 2015;55:384-389. https://doi.org/10.1111/ajo.12366
- Woo HY, Kim KH, Rhee EJ, Park H, Lee MK. Differences of the association of anti-Mullerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Endocr J 2012;59:781-790. https://doi.org/10.1507/endocrj.EJ12-0055
- Han X, McShane M, Sahertian R, White C, Ledger W. Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay. Hum Reprod 2014;29:1042-1048. https://doi.org/10.1093/humrep/deu050
- Carmina E, Campagna AM, Mansuet P, Vitale G, Kort D, Lobo R. Does the level of serum antimullerian hormone predict ovulatory function in women with polycystic ovary syndrome with aging? Fertil Steril 2012;98:1043-1046. https://doi.org/10.1016/j.fertnstert.2012.06.017
피인용 문헌
- Simplified 4‐item criteria for polycystic ovary syndrome: A bridge too far? vol.89, pp.2, 2017, https://doi.org/10.1111/cen.13755
- AMH 수치가 상승된 희발월경 환자 증례보고 vol.31, pp.3, 2017, https://doi.org/10.15204/jkobgy.2018.31.3.152
- Can we use serum Anti-Mullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patients and healthy women with polycystic ovarian morphology and regular menstrual cycles vol.39, pp.10, 2017, https://doi.org/10.15537/smj.2018.10.23413
- Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome vol.82, pp.None, 2017, https://doi.org/10.1016/j.reprotox.2018.09.006
- The role of anti-Müllerian hormone in predicting clomiphene citrate resistance in women with polycystic ovarian syndrome vol.35, pp.1, 2017, https://doi.org/10.1080/09513590.2018.1499085
- Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms vol.9, pp.4, 2017, https://doi.org/10.3390/diagnostics9040136
- A prospective study of anti‐mullerian hormone and other ovarian and adrenal hormones in adult female acne vol.33, pp.6, 2020, https://doi.org/10.1111/dth.13974